Mineralys Therapeutics presents new lorundrostat data at AHA Hypertension Sessions
Mineralys Therapeutics (MLYS) presented new data for lorundrostat at the American Heart Association Hypertension Scientific Sessions 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.